Mpox vaccination significantly reduces disease severity compared with no vaccination, although protection may wane 2 years after the last dose.
Among patients with AD, receipt of JAK inhibitors was associated with an increased risk for acne compared with Th2 cytokine inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results